14-24210455-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014169.5(CHMP4A):āc.503T>Cā(p.Leu168Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,613,900 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000046 ( 0 hom., cov: 31)
Exomes š: 0.000077 ( 1 hom. )
Consequence
CHMP4A
NM_014169.5 missense
NM_014169.5 missense
Scores
11
4
3
Clinical Significance
Conservation
PhyloP100: 8.88
Genes affected
CHMP4A (HGNC:20274): (charged multivesicular body protein 4A) CHMP4A belongs to the chromatin-modifying protein/charged multivesicular body protein (CHMP) family. These proteins are components of ESCRT-III (endosomal sorting complex required for transport III), a complex involved in degradation of surface receptor proteins and formation of endocytic multivesicular bodies (MVBs). Some CHMPs have both nuclear and cytoplasmic/vesicular distributions, and one such CHMP, CHMP1A (MIM 164010), is required for both MVB formation and regulation of cell cycle progression (Tsang et al., 2006 [PubMed 16730941]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP4A | NM_014169.5 | c.503T>C | p.Leu168Pro | missense_variant | 5/6 | ENST00000347519.12 | NP_054888.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP4A | ENST00000347519.12 | c.503T>C | p.Leu168Pro | missense_variant | 5/6 | 1 | NM_014169.5 | ENSP00000324205.11 | ||
ENSG00000254692 | ENST00000530611.1 | c.503T>C | p.Leu168Pro | missense_variant | 5/10 | 2 | ENSP00000433967.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152036Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
7
AN:
152036
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251398Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135872
GnomAD3 exomes
AF:
AC:
30
AN:
251398
Hom.:
AF XY:
AC XY:
26
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461864Hom.: 1 Cov.: 32 AF XY: 0.000118 AC XY: 86AN XY: 727236
GnomAD4 exome
AF:
AC:
113
AN:
1461864
Hom.:
Cov.:
32
AF XY:
AC XY:
86
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152036Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74262
GnomAD4 genome
AF:
AC:
7
AN:
152036
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
74262
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
13
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.632T>C (p.L211P) alteration is located in exon 5 (coding exon 5) of the CHMP4A gene. This alteration results from a T to C substitution at nucleotide position 632, causing the leucine (L) at amino acid position 211 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;.;D;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;.;.;H;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;.;.;D
REVEL
Pathogenic
Sift
Pathogenic
.;D;.;.;D
Sift4G
Pathogenic
D;D;D;D;.
Polyphen
1.0
.;.;.;D;.
Vest4
MutPred
0.55
.;Gain of glycosylation at L211 (P = 0.0245);.;.;.;
MVP
MPC
0.33
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at